Cognito (device for the treatment of neurodegenerative diseases)

2023: Device Announcement

Technology company Cognito Therapeutics has developed a wearable device designed to treat neurodegenerative disorders, specifically Alzheimer's disease. The startup, founded in 2016, raised $73 million during the Series B funding round, which was announced on March 22, 2023.

Cognito Therapeutics notes that Alzheimer's disease is one of the most acute problems of world health. There is therefore a need to develop new therapies that could help delay the onset or slow the progression of this neurodegenerative condition. A new device called Cognito, created by a startup, is designed to solve these problems.

Device for the treatment of neurodegenerative diseases Cognito

The gadget is a headset for wearing on the head. It uses acoustic and visual gamma-sensory stimulation with a frequency of 40 Hz. The principle of operation of the device is to change nervous activity through external stimuli. The light emitted by the device is like flickering, and barely audible sounds are like soft clicks or ticking. Patients can wear the headset at home - without having to visit the clinic.

It is said that the funds raised will help Cognito Therapeutics develop new methods of treating neurodegenerative diseases. The Series B funding round was led by FoundersX Ventures, and other investors included Starbloom Capital, IAG Capital, WS Investment Company and ADDF (Alzheimer's Drug Discovery Foundation). Thus, a total of $93 million has been raised by the startup since its formation.

This funding will accelerate the development of Cognito's home wearable device, which could potentially be a new and safe therapeutic solution for treating neurodegenerative diseases starting with Alzheimer's disease, the company says.[1]

Notes